Ivana Magovcevic-Liebisch
CIK 1279281 · President and CEO · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$149.0K
Companies
7
Total Filings
55
Lifetime Open-Market Net
-$882.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 3 | 2026-05-20 |
| QTRX | Director | 43,607 | $3.10 | $135.2K | $0 | 3 | 2026-01-15 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | President and CEO | 0 | $8.05 | $0 | $61.8K | 11 | 2025-08-05 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 6 | 2023-06-30 |
| ABSI | Director | — | $6.80 | — | $0 | 1 | 2022-06-10 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 3,000 | $0.39 | $1.2K | $28.9K | 11 | 2021-12-02 |
| DYAX CORP (DYAX) Delisted | EVP; Chief Operating Officer | 255,984 | — | — | -$972.7K | 20 | 2013-03-29 |
Recent Filings · Page 4 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-02 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-17 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Buy (P) | +3,000 | $28.9K | EDGAR |
| 2015-12-04 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-28 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-23 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-29 | DYAX CORP (DYAX) Delisted | Mixed | — | $0 | EDGAR |
| 2013-03-08 | DYAX CORP (DYAX) Delisted | Mixed | −7,860 | -$408.8K | EDGAR |
| 2013-02-27 | DYAX CORP (DYAX) Delisted | Sell (S) | −4,015 | -$13.0K | EDGAR |
| 2013-02-11 | DYAX CORP (DYAX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-12 | DYAX CORP (DYAX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.